References
- Lovic D, Piperidou A, Zografou I, Grassos H, Pittaras A, Manolis A. The growing epidemic of diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):104–109. doi:10.2174/1570161117666190405165911
- Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci. 2021;8(18):2100275. doi:10.1002/advs.202100275
- Pittas AG, Jorde R, Kawahara T, Dawson-Hughes B. Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D? J Clin Endocrinol Metab. 2020;105(12):3721–3733. doi:10.1210/clinem/dgaa594
- de la Guía-Galipienso F, Martínez-Ferran M, Vallecillo N, Lavie CJ, Sanchis-Gomar F, Pareja-Galeano H. Vitamin D and cardiovascular health. Clin Nutr. 2021;40(5):2946–2957. doi:10.1016/j.clnu.2020.12.025
- Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385
- Yang M, Liu J, Zhou X, et al. Correlation analysis between serum vitamin D levels and lower extremity macrovascular complications in individuals with type 2 diabetes mellitus. J Diabetes Res. 2019;2019:4251829. doi:10.1155/2019/4251829
- Sheng G, Liu D, Kuang M, Zhong Y, Zhang S, Zou Y. Utility of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in evaluating incident diabetes risk. DMSO. 2022;15:1677–1686. doi:10.2147/DMSO.S355980
- Sheng G, Kuang M, Yang R, Zhong Y, Zhang S, Zou Y. Evaluation of the value of conventional and unconventional lipid parameters for predicting the risk of diabetes in a non-diabetic population. J Transl Med. 2022;20(1):266. doi:10.1186/s12967-022-03470-z
- Wang A, Li Y, Zhou L, et al. Non-HDL-C/HDL-C ratio is associated with carotid plaque stability in general population: a cross-sectional study. Front Neurol. 2022;13:875134. doi:10.3389/fneur.2022.875134
- Kim SW, Jee JH, Kim HJ, et al. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol. 2013;168(3):2678–2683. doi:10.1016/j.ijcard.2013.03.027
- Kwok RM, Torres DM, Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? Hepatology. 2013;58(3):1166–1174. doi:10.1002/hep.26390
- Surdu AM, Pînzariu O, Ciobanu D-M, et al. Vitamin D and its role in the lipid metabolism and the development of atherosclerosis. Biomedicines. 2021;9(2):172. doi:10.3390/biomedicines9020172
- Lee H, Lee H, Lim Y. Vitamin D3 improves lipophagy-associated renal lipid metabolism and tissue damage in diabetic mice. Nutr Res. 2020;80:55–65. doi:10.1016/j.nutres.2020.06.007
- Zhang N, Hu X, Zhang Q, et al. Non-high-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort study. J Diabetes. 2018;10(9):708–714. doi:10.1111/1753-0407.12650
- Pludowski P, Takacs I, Boyanov M, et al. Clinical practice in the prevention, diagnosis and treatment of vitamin D deficiency: a central and eastern European expert consensus statement. Nutrients. 2022;14(7):1483. doi:10.3390/nu14071483
- Zakaria WNA, Mohd Yunus N, Yaacob NM, et al. Association between vitamin D receptor polymorphisms (BsmI and FokI) and glycemic control among patients with type 2 diabetes. Int J Environ Res Public Health. 2021;18(4):1595. doi:10.3390/ijerph18041595
- Dai J, Yu M, Chen H, Chai Y. Association between serum 25-OH-vitamin D and diabetic foot ulcer in patients with type 2 diabetes. Front Nutr. 2020;7:109. doi:10.3389/fnut.2020.00109
- Szymczak-Pajor I, Drzewoski J, Śliwińska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci. 2020;21(18):6644. doi:10.3390/ijms21186644
- Ekmekcioglu C, Haluza D, Kundi M. 25-hydroxyvitamin D status and risk for colorectal cancer and type 2 diabetes mellitus: a systematic review and meta-analysis of epidemiological studies. IJERPH. 2017;14(2):127. doi:10.3390/ijerph14020127
- Zhao Y, Chen C, Pan W, et al. Comparative efficacy of vitamin D status in reducing the risk of bladder cancer: a systematic review and network meta-analysis. Nutrition. 2016;32(5):515–523. doi:10.1016/j.nut.2015.10.023
- Tomlinson B, Patil NG, Fok M, Lam CWK. Managing dyslipidemia in patients with Type 2 diabetes. Expert Opin Pharmacother. 2021;22(16):2221–2234. doi:10.1080/14656566.2021.1912734
- Kjeldsen EW, Nordestgaard LT, Frikke-Schmidt R. HDL cholesterol and non-cardiovascular disease: a narrative review. Int J Mol Sci. 2021;22(9):4547. doi:10.3390/ijms22094547
- Narvaez CJ, Simmons KM, Brunton J, Salinero A, Chittur SV, Welsh JE. Induction of STEAP4 correlates with 1,25-dihydroxyvitamin D 3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue: VITAMIN D, STEAP4 AND ADIPOGENESIS. J Cell Physiol. 2013;228(10):2024–2036. doi:10.1002/jcp.24371
- El-Sharkawy A, Malki A. Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications. Molecules. 2020;25(14):3219. doi:10.3390/molecules25143219
- Lin D, Qi Y, Huang C, et al. Associations of lipid parameters with insulin resistance and diabetes: a population-based study. Clin Nutr. 2018;37(4):1423–1429. doi:10.1016/j.clnu.2017.06.018
- Jia Y, Song T, Li Z, Zhou L, Chen S. The relationship between triglyceride glucose index and vitamin D in type 2 diabetes mellitus. DMSO. 2022;15:511–525. doi:10.2147/DMSO.S348845
- Zhao X, Deng C, Li Z, Jia Y, Chen S. Monocyte/high-density lipoprotein cholesterol ratio predicts vitamin D deficiency in male patients with type 2 diabetes mellitus. DMSO. 2022;15:2455–2466. doi:10.2147/DMSO.S376127